Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - CHANGE IN WORKING CAPITAL
Change in Working Capital KALV - KalVista Pharmaceuticals, Inc.
15.2 M
LAST VALUE
79.75%
2 YEAR CAGR
22.93%
5 YEAR CAGR
41.85%
10 YEAR CAGR